Profile data is unavailable for this security.
About the company
Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.
- Revenue in USD (TTM)414.10m
- Net income in USD52.20m
- Incorporated2021
- Employees5.50k
- LocationProcaps Group SA9, rue de BitbourgLUXEMBOURG 1273LuxembourgLUX
- Websitehttps://www.procapsgroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XOMA Corp | 5.81m | -45.09m | 296.78m | 13.00 | -- | 3.61 | -- | 51.07 | -3.92 | -3.92 | 0.5053 | 7.08 | 0.0329 | -- | 1,291.33 | 447,000.00 | -22.44 | -4.55 | -24.19 | -4.94 | -- | -- | -681.69 | -31.87 | -- | -24.55 | 0.5944 | -- | -21.06 | -2.13 | -105.10 | -- | 23.16 | -- |
| CytoDyn Inc | 0.00 | -51.69m | 297.95m | 12.00 | -- | -- | -- | -- | -0.055 | -0.055 | 0.00 | -0.1206 | 0.00 | -- | -- | 0.00 | -414.98 | -259.98 | -- | -- | -- | -- | -- | -235,303.80 | -- | -0.88 | -- | -- | -100.00 | -- | 62.14 | -- | -- | -- |
| Atea Pharmaceuticals Inc | 0.00 | -163.66m | 304.05m | 74.00 | -- | 0.6028 | -- | -- | -1.96 | -1.96 | 0.00 | 5.99 | 0.00 | -- | -- | 0.00 | -27.48 | -5.90 | -28.78 | -6.98 | -- | -- | -- | -38.91 | -- | -- | 0.00 | -- | -- | -- | -17.30 | -- | -- | -- |
| Q32 Bio Inc | 354.00k | -83.09m | 313.12m | 39.00 | -- | 6.41 | -- | 884.53 | -25.73 | -25.73 | 0.1182 | 4.09 | 0.002 | -- | -- | 50,571.43 | -34.17 | -34.98 | -40.05 | -37.92 | -- | -- | -16,901.98 | -971.76 | -- | -- | 0.2039 | -- | -63.97 | -26.32 | -2,156.96 | -- | -60.90 | -- |
| Fractyl Health Inc | 148.00k | -83.16m | 314.68m | 102.00 | -- | 3.74 | -- | 2,126.23 | -1.73 | -1.73 | 0.0031 | 1.76 | -- | -- | -- | 1,450.98 | -- | -- | -- | -- | 37.16 | -- | -46,270.95 | -- | 9.37 | -5.10 | 0.2542 | -- | -- | -- | -48.15 | -- | -- | -- |
| Procaps Group SA | 414.10m | 52.20m | 314.78m | 5.50k | 5.36 | 7.99 | 4.52 | 0.7602 | 0.5209 | 0.5209 | 4.16 | 0.3491 | 0.854 | 1.87 | 3.38 | 75,290.18 | 10.77 | -- | 19.01 | -- | 55.04 | -- | 12.61 | -- | 0.9861 | -- | 0.8829 | -- | 0.0434 | -- | 142.18 | -- | -- | -- |
| Replimune Group Inc | 0.00 | -215.79m | 318.13m | 331.00 | -- | 0.8495 | -- | -- | -3.24 | -3.24 | 0.00 | 6.10 | 0.00 | -- | -- | 0.00 | -38.05 | -29.08 | -40.71 | -30.56 | -- | -- | -- | -- | -- | -- | 0.1593 | -- | -- | -- | -23.82 | -- | 16.84 | -- |
| Agenus Inc | 161.42m | -239.61m | 320.24m | 389.00 | -- | -- | -- | 1.98 | -12.68 | -12.68 | 8.49 | -9.59 | 0.4823 | -- | 170.54 | 414,951.20 | -74.69 | -55.02 | -242.74 | -115.31 | 99.43 | -- | -154.88 | -102.92 | -- | -1.25 | -- | -- | 59.47 | 33.56 | -11.66 | -- | 22.58 | -- |
| Foghorn Therapeutics Inc. | 33.90m | -92.95m | 320.91m | 116.00 | -- | -- | -- | 9.47 | -2.21 | -2.21 | 0.8046 | -2.29 | 0.108 | -- | -- | 292,206.90 | -29.61 | -31.35 | -35.75 | -35.69 | -- | -- | -274.23 | -777.33 | -- | -- | -- | -- | 77.63 | -- | 9.60 | -- | -4.50 | -- |
| Nautilus Biotechnology Inc | 0.00 | -67.44m | 323.18m | 163.00 | -- | 1.30 | -- | -- | -0.5402 | -0.5402 | 0.00 | 1.99 | 0.00 | -- | -- | 0.00 | -21.26 | -- | -21.85 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -9.93 | -- | -- | -- |
| Tenaya Therapeutics Inc | 0.00 | -124.58m | 325.06m | 140.00 | -- | 2.06 | -- | -- | -1.65 | -1.65 | 0.00 | 2.01 | 0.00 | -- | -- | 0.00 | -57.91 | -- | -63.59 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.3388 | -- | -- | -- |
| Alto Neuroscience Inc | 0.00 | -42.44m | 330.14m | 67.00 | -- | 1.71 | -- | -- | -1.90 | -1.90 | 0.00 | 7.18 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.049 | -- | -- | -- | -31.02 | -- | -- | -- |
| MeiraGTx Holdings PLC | 11.38m | -74.11m | 330.54m | 402.00 | -- | 2.71 | -- | 29.05 | -1.27 | -1.27 | 0.1887 | 1.89 | 0.0381 | -- | 0.4821 | 27,159.90 | -24.81 | -26.40 | -31.62 | -32.66 | -- | -- | -651.19 | -420.70 | -- | -27.54 | 0.3729 | -- | -11.95 | -- | 35.17 | -- | 12.37 | -- |
| Zura Bio Ltd | 0.00 | -60.18m | 334.34m | 14.00 | -- | 3.75 | -- | -- | -1.63 | -1.63 | 0.00 | 1.40 | 0.00 | -- | -- | 0.00 | -86.77 | -- | -127.21 | -- | -- | -- | -- | -- | -- | -- | 0.021 | -- | -- | -- | -2,050.99 | -- | -- | -- |
Data as of May 28 2024. Currency figures normalised to Procaps Group SA's reporting currency: US Dollar USD
0.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Credicorp Capital Asset Management SA AGFas of 30 Jun 2023 | 253.55k | 0.23% |
| Lemanik Asset Management SAas of 30 Jun 2023 | 101.57k | 0.09% |
| Geode Capital Management LLCas of 31 Mar 2024 | 28.94k | 0.03% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 25.30k | 0.02% |
| Citadel Securities LLCas of 31 Mar 2024 | 12.50k | 0.01% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 12.36k | 0.01% |
| Activest Wealth Management LLCas of 31 Mar 2024 | 10.00k | 0.01% |
| RBC Dominion Securities, Inc.as of 31 Mar 2024 | 362.00 | 0.00% |
| Pineridge Advisors LLCas of 31 Mar 2024 | 250.00 | 0.00% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Mar 2024 | 100.00 | 0.00% |
More ▼
Data from 29 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
